已收录 268921 条政策
 政策提纲
  • 暂无提纲
Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain
[摘要] Histone deacetylases (HDACs) regulate gene expression by inducing conformational changes in chromatin. Ever since the discovery of a naturally occurring HDAC inhibitor, trichostatin A (TSA) stimulated the recent development of suberoylanilide (SAHA, Zolinza (R)), HDAC has become an important molecular target for drug development. This has created the need to develop specific in vivo radioligands to study epigenetic regulation and HDAC engagement for drug development for diseases including cancer and disorders. 6-([F-18]Fluoroacetamido)-1-hexanoicanilide ([F-18]FAHA) was recently developed as a HDAC substrate and shows moderate blood-brain barrier (BBB) permeability and specific signal (by metabolic trapping/or deacetylation) but rapid metabolism. Here, we report the radiosynthesis of two carbon-11 labeled candidate radiotracers (substrate-and inhibitor-based radioligand) for HDAC and their evaluation in non-human primate brain. PET studies showed very low brain uptake and rapid metabolism of both labeled compounds but revealed a surprising enhancement of brain penetration by F for H substitution when comparing one of these to [F-18]FAHA. Further structural refinement is needed for the development of brain-penetrant, metabolically stable HDAC radiotracers and to understand the role of fluorine substitution on brain penetration. Published by Elsevier Ltd.
[发布日期] 2013-12-15 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Carbon-11;Positron emission tomography;SAHA;Brain;Epigenetics;Brain permeability [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文